Concordance Study Between IBM Watson for Oncology and Clinical Practice for Patients with Cancer in China

BACKGROUND. IBM Watson for Oncology (WFO), which can use natural language processing to evaluate data in structured and unstructured formats, has begun to be used in China. It provides physicians with evidence‐based treatment options and ranks them in three categories for treatment decision support....

詳細記述

保存先:
書誌詳細
出版年:Oncologist
主要な著者: Zhou, Na, Zhang, Chuan‐Tao, Lv, Hong‐Ying, Hao, Chen‐Xing, Li, Tian‐Jun, Zhu, Jing‐Juan, Zhu, Hua, Jiang, Man, Liu, Ke‐Wei, Hou, He‐Lei, Liu, Dong, Li, Ai‐Qin, Zhang, Guo‐Qing, Tian, Zi‐Bin, Zhang, Xiao‐Chun
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley & Sons, Inc. 2018
主題:
Global Health and Cancer
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6656482/
https://ncbi.nlm.nih.gov/pubmed/30181315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0255
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料